Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung

Gespeichert in:

Autor*in:	Huber, Eva Maria [verfasserIn] Groll, Michael

Format:	Artikel

Erschienen:	2012

Systematik:	VA 2100

Umfang:	13

Übergeordnetes Werk:	Enthalten in: Angewandte Chemie - Weinheim : Wiley-VCH Verl., 1932, 124(2012), 35 vom: Aug., Seite 8838-8851
Übergeordnetes Werk:	volume:124 ; year:2012 ; number:35 ; month:08 ; pages:8838-8851 ; extent:13

Katalog-ID:	OLC1901923886

Internformat


LEADER	01000caa a22002652 4500
001	OLC1901923886
003	DE-627
005	20230713102501.0
007	tu
008	120824s2012 xx \|\|\|\|\| 00\| \|\|und c
028	5	2	\|a sw120822_1
035			\|a (DE-627)OLC1901923886
035			\|a (DE-599)GBVOLC1901923886
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
082	0	4	\|a 540 \|a 660
082	0	4	\|a 660 \|q AVZ
082	0	4	\|a 540 \|q AVZ
084			\|a VA 2100 \|q AVZ \|2 rvk
100	1		\|a Huber, Eva Maria \|e verfasserin \|4 aut
245	1	0	\|a Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung
264		1	\|c 2012
300			\|a 13
336			\|a Text \|b txt \|2 rdacontent
337			\|a ohne Hilfsmittel zu benutzen \|b n \|2 rdamedia
338			\|a Band \|b nc \|2 rdacarrier
700	1		\|a Groll, Michael \|4 oth
773	0	8	\|i Enthalten in \|t Angewandte Chemie \|d Weinheim : Wiley-VCH Verl., 1932 \|g 124(2012), 35 vom: Aug., Seite 8838-8851 \|w (DE-627)130124907 \|w (DE-600)506609-8 \|w (DE-576)015658813 \|x 0044-8249 \|7 nnns
773	1	8	\|g volume:124 \|g year:2012 \|g number:35 \|g month:08 \|g pages:8838-8851 \|g extent:13
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a SSG-OLC-TEC
912			\|a SSG-OLC-CHE
912			\|a SSG-OLC-DE-84
912			\|a GBV_ILN_11
912			\|a GBV_ILN_22
912			\|a GBV_ILN_24
912			\|a GBV_ILN_30
912			\|a GBV_ILN_31
912			\|a GBV_ILN_32
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_160
912			\|a GBV_ILN_267
912			\|a GBV_ILN_285
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2006
912			\|a GBV_ILN_2010
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2016
912			\|a GBV_ILN_2018
912			\|a GBV_ILN_2020
912			\|a GBV_ILN_2095
912			\|a GBV_ILN_2185
912			\|a GBV_ILN_2234
912			\|a GBV_ILN_2411
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4046
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4700
936	r	v	\|a VA 2100
951			\|a AR
952			\|d 124 \|j 2012 \|e 35 \|c 8 \|h 8838-8851 \|g 13

Indexfelder

author_variant	e m h em emh
matchkey_str	article:00448249:2012----::niioefdsosiuiertaoudaimnpoesmkulenzkfieedn
hierarchy_sort_str	2012
publishDate	2012
allfields	sw120822_1 (DE-627)OLC1901923886 (DE-599)GBVOLC1901923886 DE-627 ger DE-627 rakwb 540 660 660 AVZ 540 AVZ VA 2100 AVZ rvk Huber, Eva Maria verfasserin aut Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung 2012 13 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Groll, Michael oth Enthalten in Angewandte Chemie Weinheim : Wiley-VCH Verl., 1932 124(2012), 35 vom: Aug., Seite 8838-8851 (DE-627)130124907 (DE-600)506609-8 (DE-576)015658813 0044-8249 nnns volume:124 year:2012 number:35 month:08 pages:8838-8851 extent:13 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-TEC SSG-OLC-CHE SSG-OLC-DE-84 GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_32 GBV_ILN_69 GBV_ILN_70 GBV_ILN_160 GBV_ILN_267 GBV_ILN_285 GBV_ILN_2004 GBV_ILN_2006 GBV_ILN_2010 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2018 GBV_ILN_2020 GBV_ILN_2095 GBV_ILN_2185 GBV_ILN_2234 GBV_ILN_2411 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4700 VA 2100 AR 124 2012 35 8 8838-8851 13
spelling	sw120822_1 (DE-627)OLC1901923886 (DE-599)GBVOLC1901923886 DE-627 ger DE-627 rakwb 540 660 660 AVZ 540 AVZ VA 2100 AVZ rvk Huber, Eva Maria verfasserin aut Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung 2012 13 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Groll, Michael oth Enthalten in Angewandte Chemie Weinheim : Wiley-VCH Verl., 1932 124(2012), 35 vom: Aug., Seite 8838-8851 (DE-627)130124907 (DE-600)506609-8 (DE-576)015658813 0044-8249 nnns volume:124 year:2012 number:35 month:08 pages:8838-8851 extent:13 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-TEC SSG-OLC-CHE SSG-OLC-DE-84 GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_32 GBV_ILN_69 GBV_ILN_70 GBV_ILN_160 GBV_ILN_267 GBV_ILN_285 GBV_ILN_2004 GBV_ILN_2006 GBV_ILN_2010 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2018 GBV_ILN_2020 GBV_ILN_2095 GBV_ILN_2185 GBV_ILN_2234 GBV_ILN_2411 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4700 VA 2100 AR 124 2012 35 8 8838-8851 13
allfields_unstemmed	sw120822_1 (DE-627)OLC1901923886 (DE-599)GBVOLC1901923886 DE-627 ger DE-627 rakwb 540 660 660 AVZ 540 AVZ VA 2100 AVZ rvk Huber, Eva Maria verfasserin aut Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung 2012 13 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Groll, Michael oth Enthalten in Angewandte Chemie Weinheim : Wiley-VCH Verl., 1932 124(2012), 35 vom: Aug., Seite 8838-8851 (DE-627)130124907 (DE-600)506609-8 (DE-576)015658813 0044-8249 nnns volume:124 year:2012 number:35 month:08 pages:8838-8851 extent:13 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-TEC SSG-OLC-CHE SSG-OLC-DE-84 GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_32 GBV_ILN_69 GBV_ILN_70 GBV_ILN_160 GBV_ILN_267 GBV_ILN_285 GBV_ILN_2004 GBV_ILN_2006 GBV_ILN_2010 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2018 GBV_ILN_2020 GBV_ILN_2095 GBV_ILN_2185 GBV_ILN_2234 GBV_ILN_2411 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4700 VA 2100 AR 124 2012 35 8 8838-8851 13
allfieldsGer	sw120822_1 (DE-627)OLC1901923886 (DE-599)GBVOLC1901923886 DE-627 ger DE-627 rakwb 540 660 660 AVZ 540 AVZ VA 2100 AVZ rvk Huber, Eva Maria verfasserin aut Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung 2012 13 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Groll, Michael oth Enthalten in Angewandte Chemie Weinheim : Wiley-VCH Verl., 1932 124(2012), 35 vom: Aug., Seite 8838-8851 (DE-627)130124907 (DE-600)506609-8 (DE-576)015658813 0044-8249 nnns volume:124 year:2012 number:35 month:08 pages:8838-8851 extent:13 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-TEC SSG-OLC-CHE SSG-OLC-DE-84 GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_32 GBV_ILN_69 GBV_ILN_70 GBV_ILN_160 GBV_ILN_267 GBV_ILN_285 GBV_ILN_2004 GBV_ILN_2006 GBV_ILN_2010 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2018 GBV_ILN_2020 GBV_ILN_2095 GBV_ILN_2185 GBV_ILN_2234 GBV_ILN_2411 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4700 VA 2100 AR 124 2012 35 8 8838-8851 13
allfieldsSound	sw120822_1 (DE-627)OLC1901923886 (DE-599)GBVOLC1901923886 DE-627 ger DE-627 rakwb 540 660 660 AVZ 540 AVZ VA 2100 AVZ rvk Huber, Eva Maria verfasserin aut Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung 2012 13 Text txt rdacontent ohne Hilfsmittel zu benutzen n rdamedia Band nc rdacarrier Groll, Michael oth Enthalten in Angewandte Chemie Weinheim : Wiley-VCH Verl., 1932 124(2012), 35 vom: Aug., Seite 8838-8851 (DE-627)130124907 (DE-600)506609-8 (DE-576)015658813 0044-8249 nnns volume:124 year:2012 number:35 month:08 pages:8838-8851 extent:13 GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-TEC SSG-OLC-CHE SSG-OLC-DE-84 GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_32 GBV_ILN_69 GBV_ILN_70 GBV_ILN_160 GBV_ILN_267 GBV_ILN_285 GBV_ILN_2004 GBV_ILN_2006 GBV_ILN_2010 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2018 GBV_ILN_2020 GBV_ILN_2095 GBV_ILN_2185 GBV_ILN_2234 GBV_ILN_2411 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4700 VA 2100 AR 124 2012 35 8 8838-8851 13
source	Enthalten in Angewandte Chemie 124(2012), 35 vom: Aug., Seite 8838-8851 volume:124 year:2012 number:35 month:08 pages:8838-8851 extent:13
sourceStr	Enthalten in Angewandte Chemie 124(2012), 35 vom: Aug., Seite 8838-8851 volume:124 year:2012 number:35 month:08 pages:8838-8851 extent:13
format_phy_str_mv	Article
institution	findex.gbv.de
dewey-raw	540
isfreeaccess_bool	false
container_title	Angewandte Chemie
authorswithroles_txt_mv	Huber, Eva Maria @@aut@@ Groll, Michael @@oth@@
publishDateDaySort_date	2012-08-01T00:00:00Z
hierarchy_top_id	130124907
dewey-sort	3540
id	OLC1901923886
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">OLC1901923886</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230713102501.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">120824s2012 xx \|\|\|\|\| 00\| \|\|und c</controlfield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">sw120822_1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1901923886</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1901923886</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">660</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">660</subfield><subfield code="q">AVZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">AVZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VA 2100</subfield><subfield code="q">AVZ</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Huber, Eva Maria</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">13</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Groll, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Angewandte Chemie</subfield><subfield code="d">Weinheim : Wiley-VCH Verl., 1932</subfield><subfield code="g">124(2012), 35 vom: Aug., Seite 8838-8851</subfield><subfield code="w">(DE-627)130124907</subfield><subfield code="w">(DE-600)506609-8</subfield><subfield code="w">(DE-576)015658813</subfield><subfield code="x">0044-8249</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:124</subfield><subfield code="g">year:2012</subfield><subfield code="g">number:35</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:8838-8851</subfield><subfield code="g">extent:13</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-TEC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-CHE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_30</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_160</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_267</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2016</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2018</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2095</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2185</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2234</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2411</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4046</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="936" ind1="r" ind2="v"><subfield code="a">VA 2100</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">124</subfield><subfield code="j">2012</subfield><subfield code="e">35</subfield><subfield code="c">8</subfield><subfield code="h">8838-8851</subfield><subfield code="g">13</subfield></datafield></record></collection>
author	Huber, Eva Maria
spellingShingle	Huber, Eva Maria ddc 540 ddc 660 rvk VA 2100 Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung
authorStr	Huber, Eva Maria
ppnlink_with_tag_str_mv	@@773@@(DE-627)130124907
format	Article
dewey-ones	540 - Chemistry & allied sciences 660 - Chemical engineering
delete_txt_mv	keep
author_role	aut
collection	OLC
remote_str	false
illustrated	Not Illustrated
issn	0044-8249
topic_title	540 660 660 AVZ 540 AVZ VA 2100 AVZ rvk Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung
topic	ddc 540 ddc 660 rvk VA 2100
topic_unstemmed	ddc 540 ddc 660 rvk VA 2100
topic_browse	ddc 540 ddc 660 rvk VA 2100
format_facet	Aufsätze Gedruckte Aufsätze
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	nc
author2_variant	m g mg
hierarchy_parent_title	Angewandte Chemie
hierarchy_parent_id	130124907
dewey-tens	540 - Chemistry 660 - Chemical engineering
hierarchy_top_title	Angewandte Chemie
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)130124907 (DE-600)506609-8 (DE-576)015658813
title	Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung
ctrlnum	(DE-627)OLC1901923886 (DE-599)GBVOLC1901923886
title_full	Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung
author_sort	Huber, Eva Maria
journal	Angewandte Chemie
journalStr	Angewandte Chemie
isOA_bool	false
dewey-hundreds	500 - Science 600 - Technology
recordtype	marc
publishDateSort	2012
contenttype_str_mv	txt
container_start_page	8838
author_browse	Huber, Eva Maria
container_volume	124
physical	13
class	540 660 660 AVZ 540 AVZ VA 2100 AVZ rvk
format_se	Aufsätze
author-letter	Huber, Eva Maria
dewey-full	540 660
title_sort	inhibitoren für das konstitutive proteasom und das immunoproteasom: aktuelle und zukünftige tendenzen in der medikamentenentwicklung
title_auth	Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_OLC SSG-OLC-TEC SSG-OLC-CHE SSG-OLC-DE-84 GBV_ILN_11 GBV_ILN_22 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_32 GBV_ILN_69 GBV_ILN_70 GBV_ILN_160 GBV_ILN_267 GBV_ILN_285 GBV_ILN_2004 GBV_ILN_2006 GBV_ILN_2010 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2018 GBV_ILN_2020 GBV_ILN_2095 GBV_ILN_2185 GBV_ILN_2234 GBV_ILN_2411 GBV_ILN_4037 GBV_ILN_4046 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4700
container_issue	35
title_short	Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung
remote_bool	false
author2	Groll, Michael
author2Str	Groll, Michael
ppnlink	130124907
mediatype_str_mv	n
isOA_txt	false
hochschulschrift_bool	false
author2_role	oth
up_date	2024-07-03T21:18:55.893Z
_version_	1803594273542635520
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">OLC1901923886</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230713102501.0</controlfield><controlfield tag="007">tu</controlfield><controlfield tag="008">120824s2012 xx \|\|\|\|\| 00\| \|\|und c</controlfield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">sw120822_1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)OLC1901923886</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBVOLC1901923886</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">660</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">660</subfield><subfield code="q">AVZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">AVZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VA 2100</subfield><subfield code="q">AVZ</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Huber, Eva Maria</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">13</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">ohne Hilfsmittel zu benutzen</subfield><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Band</subfield><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Groll, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Angewandte Chemie</subfield><subfield code="d">Weinheim : Wiley-VCH Verl., 1932</subfield><subfield code="g">124(2012), 35 vom: Aug., Seite 8838-8851</subfield><subfield code="w">(DE-627)130124907</subfield><subfield code="w">(DE-600)506609-8</subfield><subfield code="w">(DE-576)015658813</subfield><subfield code="x">0044-8249</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:124</subfield><subfield code="g">year:2012</subfield><subfield code="g">number:35</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:8838-8851</subfield><subfield code="g">extent:13</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_OLC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-TEC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-CHE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-DE-84</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_30</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_160</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_267</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2016</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2018</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2095</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2185</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2234</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2411</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4046</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="936" ind1="r" ind2="v"><subfield code="a">VA 2100</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">124</subfield><subfield code="j">2012</subfield><subfield code="e">35</subfield><subfield code="c">8</subfield><subfield code="h">8838-8851</subfield><subfield code="g">13</subfield></datafield></record></collection>
score	7.401025

Nicht das Richtige dabei?

Schreiben Sie uns!

Inhibitoren für das konstitutive Proteasom und das Immunoproteasom: aktuelle und zukünftige Tendenzen in der Medikamentenentwicklung

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?